Company Overview
Nature's Sunshine Products, Inc. operates as a natural health and wellness company that manufactures and sells nutritional and personal care products across global markets including Asia, Europe, North America, Latin America, and internationally. The firm is situated within the Consumer Defensive sector and specifically within the Packaged Foods industry, a classification that typically denotes businesses providing essential goods that demand consistent consumer spending regardless of economic cycles. The company's current scale is defined by a market capitalization of $416.16M and an annual revenue of $480.14M, supported by a workforce of 806 employees. These financial figures indicate that the organization maintains a mid-cap status with a revenue base that suggests a diversified product distribution model focused on general health products related to blood sugar support, bone health, and cell function.
Financial Health
The company reported revenue of $480.14M over the trailing twelve months, generating a net income of $19.52M and an EBITDA of $38.59M. The significant gap between the total revenue figure and the net income reveals a cost structure where operating expenses and taxes consume approximately 59% of top-line revenue before arriving at the final profit. The business generated free cash flow of $32.98M, which demonstrates a strong ability to convert earnings into cash and provides the financial flexibility to manage operations without relying on external financing. Analysis of the three primary margins shows a gross margin of 72.4%, an operating margin of 4.3%, and a profit margin of 4.1%. The high gross margin indicates substantial pricing power or low cost of goods sold relative to sales, while the lower operating and profit margins suggest that administrative, selling, and general expenses are a significant portion of the revenue stream. The balance sheet holds $93.89M in cash against $18.90M in debt, resulting in a debt-to-equity ratio of 11.70, which implies a conservative capital structure with a substantial net cash position rather than a leveraged one. Liquidity is robust as evidenced by a current ratio of 2.28, indicating that the company possesses more than double the current assets necessary to cover its short-term liabilities. Management effectiveness is reflected in a return on equity of 12.7% and a return on assets of 6.2%, metrics that show the company generates a meaningful return on the shareholders' capital and utilizes its asset base efficiently to produce earnings.
Valuation Assessment
The valuation metrics for Nature's Sunshine Products, Inc. show a trailing twelve-month P/E ratio of 22.42 and a forward P/E of 19.33. The difference between these two ratios, where the forward multiple is lower, implies that the market expects earnings growth in the future that would justify a cheaper valuation multiple compared to current earnings. The stock trades at a price-to-book ratio of 2.58, which indicates that the market values the company at a significant premium over its tangible book value, likely reflecting the intangible assets and brand equity inherent in the natural health sector. Alternative valuation metrics include a price-to-sales ratio of 0.87 and an EV/EBITDA of 8.84, suggesting that the company is valued at less than one dollar of sales for every dollar of revenue and has an enterprise value relative to earnings before interest, taxes, depreciation, and amortization that is attractive relative to industry peers. The stock has a 52-week high of $28.14 and a 52-week low of $11.01, meaning the current trading price sits well below the yearly peak but provides a wide range of volatility within the trading band. The beta value is 0.87, which explains that the stock's price volatility is slightly lower than the broader market, making it a relatively less sensitive instrument to overall market swings compared to the average stock.
Growth & Income
Nature's Sunshine Products, Inc. reported a revenue growth rate of 4.7% year over year, while the earnings growth rate is listed as N/A. The absence of a specific earnings growth figure alongside positive revenue growth implies that cost structures or one-time items may be influencing the bottom line, or that the data point is not currently available for calculation. Since the company does not pay a dividend, as indicated by a dividend yield of N/A and a payout ratio of 0.0%, it retains all earnings for reinvestment into growth initiatives, research, or balance sheet strengthening rather than distributing income to shareholders. This reinvestment strategy is common for companies in the consumer defensive sector that prioritize long-term expansion over immediate income distribution. The overall growth and income profile is characterized by steady double-digit revenue expansion without the current support of a dividend yield, relying instead on organic growth and market share gains in the global natural health market.